Showing 58 results for Disease
Our deployed service members are exposed to adversary activity and numerous naturally occurring or engineered threats including chemicals, viruses, and bacteria. To protect them, BTO is developing technologies that can rapidly detect and characterize these threats. In addition, BTO is developing novel biological approaches to sense and report adversary activities on land and at sea.
This announcement seeks revolutionary research ideas for topics not being
addressed by ongoing BTO programs or other published solicitations.
The goal of the NOW program is to develop a mobile medical countermeasure
(MCM) manufacturing platform for use in stabilization and humanitarian
operations to produce, formulate, and package hundreds of doses of nucleic
acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed
platform should be a resilient, mobile, readily accessible nucleic acid MCM
manufacturing capability that enables immediate threat response anywhere the
military operates with minimal user intervention.